Company Overview

For personal use only APIRX Intellectual Property Families 19 granted and 23 pending patents to secure commercial exclusivity and our R&D investment. Some patents meet more than one of the categories below: Extraction 3 Granted Pending 2 Cannabinoid drug development pipeline Formulation/Extraction Chewing gum (also combo products) Ultra-high bioavailability chewing gum / chewable tablet Oral care Ophthalmic solutions Suppositories Extraction of THC, CBD, CBG Cannabinoid sugar alcohol Microencapsulation of cannabinoids Sustained release technology API modification 4 Pending Incannex Methods of use |||||| Treat glaucoma and conjunctivitis Treat atopic dermatitis Antimicrobial Treat Vitiligo Treat Osteonecrosis of the jaw Treat psoriasis Formulation 17 Granted 15 Pending Methods of use 3 Granted 5 Pending Cannabinoid delivery methods with increased bioavailability and altered release profiles which provide opportunity to develop unique cannabinoid products and or products with advantages over established cannabinoid medicines. Patent lawyers engaged for all psychedelic programs. Investor Presentation 13

View entire presentation